Deciphera Pharmaceuticals, Inc.

Q2 2019 13F Holders

Symbol
DCPH
CUSIP
24344T101
Type
Equity
Class
COM
Num filings
100
Total reported value, excl. options
$525 M
Manager Report Date Value ($000) Shares Option Type